Schwarz E, Long M
Viruses. 2023; 15(6).
PMID: 37376530
PMC: 10303507.
DOI: 10.3390/v15061230.
Byas A, Ebel G
Pathogens. 2020; 9(1).
PMID: 31935992
PMC: 7168622.
DOI: 10.3390/pathogens9010048.
Lucas T, Richner J, Diamond M
J Virol. 2015; 90(5):2600-15.
PMID: 26699642
PMC: 4810731.
DOI: 10.1128/JVI.02463-15.
Swanson 2nd P, McGavern D
Curr Opin Virol. 2015; 11:44-54.
PMID: 25681709
PMC: 4456224.
DOI: 10.1016/j.coviro.2014.12.009.
Donadieu E, Bahuon C, Lowenski S, Zientara S, Coulpier M, Lecollinet S
Viruses. 2013; 5(11):2856-80.
PMID: 24284878
PMC: 3856419.
DOI: 10.3390/v5112856.
Immune responses to West Nile virus infection in the central nervous system.
Cho H, Diamond M
Viruses. 2012; 4(12):3812-30.
PMID: 23247502
PMC: 3528292.
DOI: 10.3390/v4123812.
Neuromuscular manifestations of west nile virus infection.
Leis A, Stokic D
Front Neurol. 2012; 3:37.
PMID: 22461779
PMC: 3309965.
DOI: 10.3389/fneur.2012.00037.
Progress on the development of therapeutics against West Nile virus.
Diamond M
Antiviral Res. 2009; 83(3):214-27.
PMID: 19501622
PMC: 2759769.
DOI: 10.1016/j.antiviral.2009.05.006.
Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice.
Hunsperger E, Roehrig J
J Neurovirol. 2009; 15(3):211-8.
PMID: 19444694
DOI: 10.1080/13550280902913255.
West Nile virus surveillance and diagnostics: A Canadian perspective.
Drebot M, Lindsay R, Barker I, Buck P, Fearon M, Hunter F
Can J Infect Dis. 2007; 14(2):105-14.
PMID: 18159433
PMC: 2094912.
DOI: 10.1155/2003/575341.
PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.
Samuel M, Whitby K, Keller B, Marri A, Barchet W, Williams B
J Virol. 2006; 80(14):7009-19.
PMID: 16809306
PMC: 1489062.
DOI: 10.1128/JVI.00489-06.
Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.
Hunsperger E, Roehrig J
J Neurovirol. 2006; 12(2):129-39.
PMID: 16798674
DOI: 10.1080/13550280600758341.
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.
Shrestha B, Wang T, Samuel M, Whitby K, Craft J, Fikrig E
J Virol. 2006; 80(11):5338-48.
PMID: 16699014
PMC: 1472130.
DOI: 10.1128/JVI.00274-06.
CD8+ T cells require perforin to clear West Nile virus from infected neurons.
Shrestha B, Samuel M, Diamond M
J Virol. 2005; 80(1):119-29.
PMID: 16352536
PMC: 1317548.
DOI: 10.1128/JVI.80.1.119-129.2006.
West Nile virus infection and its neurological manifestations.
Madden K
Clin Med Res. 2005; 1(2):145-50.
PMID: 15931302
PMC: 1069038.
DOI: 10.3121/cmr.1.2.145.
Neuromuscular Manifestations of Human West Nile Virus Infection.
Leis A, Stokic D
Curr Treat Options Neurol. 2004; 7(1):15-22.
PMID: 15610703
DOI: 10.1007/s11940-005-0002-6.
Role of CD8+ T cells in control of West Nile virus infection.
Shrestha B, Diamond M
J Virol. 2004; 78(15):8312-21.
PMID: 15254203
PMC: 446114.
DOI: 10.1128/JVI.78.15.8312-8321.2004.
Infection and injury of neurons by West Nile encephalitis virus.
Shrestha B, Gottlieb D, Diamond M
J Virol. 2003; 77(24):13203-13.
PMID: 14645577
PMC: 296085.
DOI: 10.1128/jvi.77.24.13203-13213.2003.
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario.
Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B
CMAJ. 2003; 168(11):1399-405.
PMID: 12771068
PMC: 155955.
